U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 12:43:57 UTC 2023
Edited
by admin
on Sat Dec 16 12:43:57 UTC 2023
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
1MH7C2X8KE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EFIZONERIMOD
USAN  
Official Name English
EFIZONERIMOD ALFA
INN  
Official Name English
MEDI-6383
Code English
IMMUNOGLOBULIN G4 (10-PROLINE) (HUMAN HEAVY CHAIN FC FRAGMENT) FUSION PROTEIN WITH TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR TRAF2 (HUMAN C-C DOMAIN FRAGMENT) FUSION PROTEIN WITH OX40L (HUMAN EXTRACELLULAR DOMAIN FRAGMENT), HEXAMER
Common Name English
MODIFIED HUMAN IMMUNOGLOBULIN G4 FC FRAGMENT (1-229) (HOMO SAPIENS IGHG4*01 DEL-CH1, (10-PROLINE (S>P))HINGE) FUSION PROTEIN WITH HUMAN TNF RECEPTOR-ASSOCIATED FACTOR 2-(310-349)-PEPTIDE (230-269) FUSION PROTEIN WITH DES-(1-50)-HUMAN TUMOR NECROSIS FACTO
Systematic Name English
Efizonerimod alfa [WHO-DD]
Common Name English
MEDI6383
Code English
IMMUNOGLOBULIN G4 (10-PROLINE) (HUMAN HEAVY CHAIN FC FRAGMENT) FUSION PROTEIN WITH TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR TRAF2 (HUMAN C-C DOMAIN FRAGMENT) FUSION PROTEIN WITH CD252 ANTIGEN (HUMAN EXTRACELLULAR DOMAIN FRAGMENT), HEXAMER
Common Name English
MEDI 6383 [WHO-DD]
Common Name English
efizonerimod alfa [INN]
Common Name English
EFIZONERIMOD [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C96040
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
Code System Code Type Description
DRUG BANK
DB15390
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
INN
10417
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
USAN
CD-167
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
NCI_THESAURUS
C118282
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
CAS
1635395-27-5
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
FDA UNII
1MH7C2X8KE
Created by admin on Sat Dec 16 12:43:57 UTC 2023 , Edited by admin on Sat Dec 16 12:43:57 UTC 2023
PRIMARY
From To
1_8 2_8
1_11 2_11
1_43 1_103
1_149 1_207
1_316 1_400
2_43 2_103
2_149 2_207
2_316 2_400
3_8 4_8
3_11 4_11
3_43 3_103
3_149 3_207
3_316 3_400
4_43 4_103
4_149 4_207
4_316 4_400
5_8 6_8
5_11 6_11
5_43 5_103
5_149 5_207
5_316 5_400
6_43 6_103
6_149 6_207
6_316 6_400
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_79
N 1_309
N 1_333
N 1_371
N 1_376
N 2_79
N 2_309
N 2_333
N 2_371
N 2_376
N 3_79
N 3_309
N 3_333
N 3_371
N 3_376
N 4_79
N 4_309
N 4_333
N 4_371
N 4_376
N 5_79
N 5_309
N 5_333
N 5_371
N 5_376
N 6_79
N 6_309
N 6_333
N 6_371
N 6_376
Related Record Type Details
EFIZONERIMOD
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966